{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:57:12Z","timestamp":1790053032135,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development of Chin","award":["2018YFC1313400"],"award-info":[{"award-number":["2018YFC1313400"]}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2019jcyj-msxmX0603"],"award-info":[{"award-number":["cstc2019jcyj-msxmX0603"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Startup Fund of CQUT","award":["2019ZD88"],"award-info":[{"award-number":["2019ZD88"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Monocyte\/macrophage-targeting delivery systems (MTDSs) have been focused upon as an emerging routine for delivering drugs to treat various macrophage-related diseases. However, the ability of MTDSs to distinguish different macrophage-related diseases and their impact on macrophage function and disease progression have not been systematically revealed, which is important for actively targeted therapeutic or diagnostic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Herein, we used dextran-modified polystyrene nanoparticles (DEX-PS) to demonstrate that modification of nanoparticles by dextran can specifically enhance their recognition by M2 macrophages in vitro, but it is obstructed by monocytes in peripheral blood according to in vivo assays. DEX-PS not only targeted and became distributed in tumors, an M2 macrophage-related disease, but was also highly distributed in an M1 macrophage-related disease, namely acute peritonitis. Thus, DEX-PS acts as a double-edged sword in these two different diseases by reeducating macrophages to a pro-inflammatory phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggest that MTDSs, even those designed based on differential expression of receptors on specific macrophage subtypes, lack the ability to distinguish different macrophage subtype-related diseases in vivo. In addition to the potential impact of these carrier materials on macrophage function, studies of MTDSs should pay greater attention to the distribution of nanoparticles in non-target macrophage-infiltrated disease sites and their impact on disease processes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-020-00721-3","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T05:06:22Z","timestamp":1605503182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The double-edged sword effect of macrophage targeting delivery system in different macrophage subsets related diseases"],"prefix":"10.1186","volume":"18","author":[{"given":"Yuchuan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0852-0687","authenticated-orcid":false,"given":"Xing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"issue":"Suppl_1","key":"721_CR1","first-page":"A14558","volume":"138","author":"JW Song","year":"2018","unstructured":"Song JW, Lee MW, Kim HJ, Joo YD, Choi JY, Oh WY, Yoo H, Park K, Kim JW. Macrophage targeted theranostic photoactivation attenuates plaque inflammation and regresses the atheroma via autophagy-induced cholesterol efflux assessed by serial in vivo imaging. Circulation. 2018;138(Suppl_1):A14558.","journal-title":"Circulation"},{"key":"721_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/adhm.201400336","volume":"3","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Mlinar LB, Nord K, Sugimoto MJ, Wonder E, Alenghat FJ, Fang Y, Tirrell M. Monocyte-targeting supramolecular micellar assemblies: a molecular diagnostic tool for atherosclerosis. Adv Health Mater. 2015;3:367\u201376.","journal-title":"Adv Health Mater."},{"key":"721_CR3","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1021\/acs.nanolett.6b02386","volume":"10","author":"X Sun","year":"2016","unstructured":"Sun X, Li W, Zhang X, Qi M, Zhang Z, Zhang XE, Cui Z. In vivo targeting and imaging of atherosclerosis using multifunctional virus-like particles of simian virus 40. Nano Lett. 2016;10:6164\u201371.","journal-title":"Nano Lett"},{"key":"721_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tips.2018.03.001","volume":"6","author":"KR Peterson","year":"2018","unstructured":"Peterson KR, Cottam MA, Kennedy AJ, Hasty AH. Macrophage-targeted therapeutics for metabolic disease. Trends Pharmacol Sci. 2018;6:536\u201346.","journal-title":"Trends Pharmacol Sci"},{"key":"721_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biomaterials.2016.09.018","volume":"110","author":"R Toita","year":"2016","unstructured":"Toita R, Kawano T, Murata M, Kang JH. Anti-obesity and anti-inflammatory effects of macrophage-targeted interleukin-10-conjugated liposomes in obese mice. Biomaterials. 2016;110:81\u20138.","journal-title":"Biomaterials"},{"key":"721_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1039\/C8BM01258J","volume":"1","author":"X Wan","year":"2019","unstructured":"Wan X, Zhang S, Wang F, Fan W, Wu C, Mao K, Wang H, Hu Z, Yang YG, Sun T. Red blood cell-derived nanovesicles for safe and efficient macrophage-targeted drug delivery in vivo. Biomater Sci. 2019;1:187\u201395.","journal-title":"Biomater Sci."},{"key":"721_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jconrel.2014.04.021","volume":"190","author":"A Singh","year":"2014","unstructured":"Singh A, Talekar M, Raikar A, Amiji M. Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases. J Control Release. 2014;190:515\u201330.","journal-title":"J Control Release"},{"key":"721_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nnano.2014.62","volume":"6","author":"BR Smith","year":"2014","unstructured":"Smith BR, Ghosn EEB, Rallapalli H, Prescher JA, Larson T, Herzenberg LA, Gambhir SS. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotechnol. 2014;6:481\u20137.","journal-title":"Nat Nanotechnol"},{"key":"721_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biomaterials.2016.04.010","volume":"96","author":"MS Sasso","year":"2016","unstructured":"Sasso MS, Lollo G, Pitorre M, Solito S, Pinton L, Valpione S, Bastiat G, Mandruzzato S, Bronte V, Marigo I. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy. Biomaterials. 2016;96:47\u201362.","journal-title":"Biomaterials"},{"key":"721_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.addr.2014.09.007","volume":"91","author":"Z Amoozgar","year":"2015","unstructured":"Amoozgar Z, Goldberg MS. Targeting myeloid cells using nanoparticles to improve cancer immunotherapy. Adv. Drug Deliver. Rev. 2015;91:38\u201351.","journal-title":"Adv. Drug Deliver. Rev."},{"key":"721_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"7203","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;7203:436\u201344.","journal-title":"Nature"},{"key":"721_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"6917","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;6917:860\u20137.","journal-title":"Nature"},{"key":"721_CR13","first-page":"1","volume":"1","author":"H Freisling","year":"2020","unstructured":"Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, Sweeting M, Muller D, Romieu I, Bazelle P. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020;1:1\u201311.","journal-title":"BMC Med."},{"key":"721_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S47149","volume":"5","author":"HT S\u00f8rensen","year":"2013","unstructured":"S\u00f8rensen HT. Multimorbidity and cancer outcomes: a for more research. Clin Epidemiol. 2013;5:1\u20132.","journal-title":"Clin Epidemiol"},{"key":"721_CR15","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.1016\/j.biomaterials.2010.05.036","volume":"26","author":"T Morishige","year":"2010","unstructured":"Morishige T, Yoshioka Y, Inakura H, Tanabe A, Yao X, Narimatsu S, Monobe Y, Imazawa T, Tsunoda S, Tsutsumi Y, Mukai Y, Okada N, Nakagawa S. The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1\u03b2 production, ROS production and endosomal rupture. Biomaterials. 2010;26:6833\u201342.","journal-title":"Biomaterials"},{"key":"721_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.mattod.2015.01.019","volume":"6","author":"R Sridharan","year":"2015","unstructured":"Sridharan R, Cameron AR, Kelly DJ, Kearney CJ, O\u2019Brien FJ. Biomaterial based modulation of macrophage polarization: a review and suggested design principles. Mater Today. 2015;6:313\u201325.","journal-title":"Mater Today"},{"key":"721_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biomaterials.2016.10.055","volume":"114","author":"W Chen","year":"2017","unstructured":"Chen W, Shen X, Hu Y, Xu K, Ran Q, Yu Y, Dai L, Yuan Z, Huang L, Shen T, Cai K. Surface functionalization of titanium implants with chitosan-catechol conjugate for suppression of ROS-induced cells damage and improvement of osteogenesis. Biomaterials. 2017;114:82\u201396.","journal-title":"Biomaterials"},{"key":"721_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs functional differentiation. Front Immunol. 2014;5:514.","journal-title":"Front Immunol."},{"key":"721_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"7446","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;7446:445\u201355.","journal-title":"Nature"},{"issue":"1","key":"721_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1172\/JCI88877","volume":"127","author":"K Eguchi","year":"2017","unstructured":"Eguchi K, Nagai R. Islet inflammation in type 2 diabetes and physiology. J Clin Invest. 2017;127(1):14\u201323.","journal-title":"J Clin Invest"},{"issue":"9","key":"721_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na YR, et al. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16(9):531\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"721_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41569-019-0265-3","volume":"17","author":"T Kuznetsova","year":"2019","unstructured":"Kuznetsova T, et al. Transcriptional and epigenetic regulation of macrophages in atherosclerosis. Nat Rev Cardiol. 2019;17(4):216\u201328.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"721_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369\u201382.","journal-title":"Nat Rev Immunol"},{"key":"721_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2019","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2019;15:123\u201347.","journal-title":"Annu Rev Pathol"},{"key":"721_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bbrc.2013.10.115","volume":"4","author":"A Laskar","year":"2013","unstructured":"Laskar A, Eilertsen J, Li W, Yuan XM. SPION primes THP1 derived M2 macrophages towards M1-like macrophages. Biochem Biophys Res Commun. 2013;4:737\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"721_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2017.01.008","volume":"122","author":"Q Wang","year":"2017","unstructured":"Wang Q, Jiang H, Li Y, Chen W, Li H, Peng K, Zhang Z, Sun X. Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials. 2017;122:10\u201322.","journal-title":"Biomaterials"},{"key":"721_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jconrel.2015.09.027","volume":"217","author":"V Bagalkot","year":"2015","unstructured":"Bagalkot V, Badgeley MA, Kampfrath T, Deiuliis JA, Rajagopalan S, Maiseyeu A. Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. J Control Release. 2015;217:243\u201355.","journal-title":"J Control Release"},{"key":"721_CR28","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.addr.2004.01.012","volume":"8","author":"CM Paulos","year":"2004","unstructured":"Paulos CM, Turk MJ, Breur GJ, Low PS. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliver Rev. 2004;8:1205\u201317.","journal-title":"Adv Drug Deliver Rev."},{"key":"721_CR29","doi-asserted-by":"publisher","first-page":"9536","DOI":"10.1021\/acsnano.7b05465","volume":"9","author":"Y Qian","year":"2017","unstructured":"Qian Y, Qiao S, Dai Y, Xu G, Dai B, Lu L, Yu X, Luo Q, Zhang Z. Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages. ACS Nano. 2017;9:9536\u201349.","journal-title":"ACS Nano"},{"key":"721_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jconrel.2011.11.013","volume":"2","author":"Z Huang","year":"2012","unstructured":"Huang Z, Zhang Z, Jiang Y, Zhang D, Chen J, Dong L, Zhang J. Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy. J Control Release. 2012;2:286\u201392.","journal-title":"J Control Release"},{"key":"721_CR31","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1016\/j.biomaterials.2012.07.022","volume":"31","author":"LW Locke","year":"2012","unstructured":"Locke LW, Mayo MW, Yoo AD, Williams MB, Berr SS. PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes. Biomaterials. 2012;31:7785\u201393.","journal-title":"Biomaterials"},{"key":"721_CR32","first-page":"1","volume":"6","author":"Z Liu","year":"2015","unstructured":"Liu Z, Roche PA. Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells. Front Physiol. 2015;6:1.","journal-title":"Front. Physiol."},{"key":"721_CR33","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1039\/C5TB02479J","volume":"12","author":"M Yang","year":"2016","unstructured":"Yang M, Ding J, Zhang Y, Chang F, Wang J, Gao Z, Zhuang X, Chen X. Activated macrophage-targeted dextran\u2013methotrexate\/folate conjugate prevents deterioration of collagen-induced arthritis in mice. J Mater Chem B. 2016;12:2102\u201313.","journal-title":"J Mater Chem B"},{"key":"721_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biomaterials.2017.03.044","volume":"131","author":"RD Heo","year":"2017","unstructured":"Heo RD, You G, Um W, Choi KY, Jeon S, Park J-S, Choi Y, Kwon S, Kim K, Kwon IC. Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis. Biomaterials. 2017;131:15\u201326.","journal-title":"Biomaterials"},{"key":"721_CR35","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/adhm.201600015","volume":"10","author":"S Han","year":"2016","unstructured":"Han S, Kwon T, Um JE, Haam S, Kim WJ. Highly selective photothermal therapy by a phenoxylated-dextran-functionalized smart carbon nanotube platform. Adv Health Mater. 2016;10:1147\u201356.","journal-title":"Adv Health Mater."},{"key":"721_CR36","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2217\/nnm-2016-0156","volume":"20","author":"F Foerster","year":"2016","unstructured":"Foerster F, Bamberger D, Schupp J, Weilb\u00e4cher M, Kaps L, Strobl S, Radi L, Diken M, Strand D, Tuettenberg A. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine. 2016;20:2663\u201377.","journal-title":"Nanomedicine"},{"key":"721_CR37","doi-asserted-by":"publisher","first-page":"1703303","DOI":"10.1002\/adfm.201703303","volume":"42","author":"T Bauleth-Ramos","year":"2017","unstructured":"Bauleth-Ramos T, Shahbazi MA, Liu D, Fontana F, Correia A, Figueiredo P, Zhang H, Martins JP, Hirvonen JT, Granja P. Nutlin-3a and cytokine co-loaded spermine-modified acetalated dextran nanoparticles for cancer chemo-immunotherapy. Adv Funct Mater. 2017;42:1703303.","journal-title":"Adv Funct Mater"},{"issue":"2","key":"721_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66(2):605\u201312.","journal-title":"Cancer Res."},{"issue":"2","key":"721_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.4942","volume":"243","author":"A Capobianco","year":"2017","unstructured":"Capobianco A, Cottone L, Monno A, Manfredi AA, Rovere-Querini P. The peritoneum: healing, immunity, and diseases. J Pathol. 2017;243(2):137\u201347.","journal-title":"J Pathol."},{"issue":"8","key":"721_CR40","first-page":"e5367","volume":"11","author":"M Beniey","year":"2019","unstructured":"Beniey M. Peritoneal metastases from breast cancer: a scoping review. Cureus. 2019;11(8):e5367.","journal-title":"Cureus."},{"key":"721_CR41","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.addr.2004.02.014","volume":"11","author":"L Brannon-Peppas","year":"2004","unstructured":"Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;11:1649\u201359.","journal-title":"Adv Drug Deliv Rev."},{"key":"721_CR42","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1021\/bc00017a001","volume":"5","author":"H Maeda","year":"1992","unstructured":"Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem. 1992;5:351\u201362.","journal-title":"Bioconjug Chem."},{"key":"721_CR43","first-page":"1061","volume":"Pt 6","author":"RC May","year":"2001","unstructured":"May RC, Machesky LM. Phagocytosis and the actin cytoskeleton. J Cell Sci. 2001;Pt 6:1061\u201377.","journal-title":"J Cell Sci."},{"key":"721_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/bj20031253","volume":"377","author":"J Rejman","year":"2004","unstructured":"Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 2004;377:159\u201369.","journal-title":"Biochem J."},{"key":"721_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nmat2344","volume":"1","author":"S Mitragotri","year":"2009","unstructured":"Mitragotri S, Lahann J. Physical approaches to biomaterial design. Nat Mater. 2009;1:15\u201323.","journal-title":"Nat Mater."},{"key":"721_CR46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1084\/jem.182.2.389","volume":"2","author":"F Sallusto","year":"1995","unstructured":"Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995;2:389\u2013400.","journal-title":"J Exp Med."},{"key":"721_CR47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.01.064","volume":"85","author":"AK Fuchs","year":"2016","unstructured":"Fuchs AK, Syrovets T, Haas KA, Loos C, Musyanovych A, Mailander V, Landfester K, Simmet T. Carboxyl- and amino-functionalized polystyrene nanoparticles differentially affect the polarization profile of M1 and M2 macrophage subsets. Biomaterials. 2016;85:78\u201387.","journal-title":"Biomaterials"},{"key":"721_CR48","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/icb.1997.18","volume":"2","author":"DL Lefkowitz","year":"1997","unstructured":"Lefkowitz DL, Lincoln JA, Lefkowitz SS, Bollen A, Moguilevsky N. Enhancement of macrophage-mediated bactericidal activity by macrophage-mannose receptor-ligand interaction. Immunol Cell Biol. 1997;2:136\u201341.","journal-title":"Immunol Cell Biol."},{"issue":"1","key":"721_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0304-4165(95)00105-0","volume":"1289","author":"A Klegeris","year":"1996","unstructured":"Klegeris A, Budd TC, Greenfield SA. Acetylcholinesterase-induced respiratory burst in macrophages: evidence for the involvement of the macrophage mannose-fucose receptor. Biochim Biophys Acta Gen Subj. 1996;1289(1):159\u201367.","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"721_CR50","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.4049\/jimmunol.159.5.2462","volume":"5","author":"Y Shibata","year":"1997","unstructured":"Shibata Y, Metzger WJ, Myrvik QN. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J Immunol. 1997;5:2462\u20137.","journal-title":"J Immunol."},{"key":"721_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1615\/CritRevImmunol.v24.i3.20","volume":"3","author":"P Allavena","year":"2004","unstructured":"Allavena P, Chieppa M, Monti P, Piemonti L. From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit Rev Immunol. 2004;3:179\u201392.","journal-title":"Crit Rev Immunol."}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-020-00721-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-020-00721-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-020-00721-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T07:39:53Z","timestamp":1697096393000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-020-00721-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1186\/s12951-020-00721-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-41726\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-41726\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"11 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study had animal ethics approval from The Army Medical University Animal Ethics Committee. The manuscript does not contain clinical studies or patient data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}